Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Depressive Symptoms in Obese Patients Undergoing Sleeve Gastrectomy
NCT06199011Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Anhui Medical University
- Start
- Jan 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
Randomised trial of esketamine in major depressive disorder (MDD) (2 arms), sponsored by The Second Affiliated Hospital of Anhui Medical University. Primary endpoint: Hamilton Depression Rating Scale at 3 months. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06199011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06199011.